Learn if your company is eligible for NIH SBIR or STTR funding, how to apply, and what to expect during each step of the application process. Multiple registrations are required to prepare your application and apply for funding.
The NIH is actively turning discovery into health by helping small businesses develop innovative technologies that improve health and save lives. See how.
Inomagen Therapeutics is a private, preclinical-stage biotechnology company developing a non-viral gene therapy that targets the underlying mechanisms of Atrial Fibrillation. To achieve safe and effective gene delivery, the company is developing a novel, patented transcatheter gene delivery system.